QT Medical announces FDA clearance of PCA 500, a resting 12-lead electrocardiogram (ECG or EKG), for use in pediatric patients. First cleared in 2018 for professional and personal use by adults 18 years and older, PCA 500's new FDA clearance expands its indication for use to all pediatric populations, including: newborns, infants, children and adolescents.

專注研發心電圖（ECG）技術的美商宇心生醫，今(9/27)宣布成功完成1200萬美元（約3.8億台幣）的B輪籌資。這筆資金由中華開發貳生醫基金、台杉資本領投，將有助美商宇心生醫加速在全球市場拓展、研發製造、與長期戰略佈局方面的推進。

Meet the PCA 500: a portable, cloud-based 12-lead ECG machine with patented technology that reduces ECG test time by seventy percent. Conventional testing requires an in-person appointment, a technician and a lengthy test process.

根據世界衛生組織(WHO)的統計，全球每年有2%的人死於糖尿病，進而創造了90億美元的家用血糖機市場。但每年有31%的人死於心血管疾病，高居十大死因之首，卻沒有醫療等級且可居家使用的12導程心電圖(Electrocardiography, ECG)檢查產品。

QT Medical 榮獲2020 美國蒂貝茲傑出發明獎 (Tibbetts Awards 2020)

QT Medical strives to make hospital grade 12-lead electrocardiograms (ECG) accessible to everyone everywhere.

宇心生醫QT Medical 誠摯邀請您蒞臨參觀 2021台灣醫療科技展

The facts are grim: One person dies from cardiovascular disease every 37 seconds in the United States. One of the most effective tests for the heart is the twelve-lead electrocardiogram (ECG).